Nerindocianine

N/A

Report date: 2023/02/18 19:46:41

Base Information

Drug NameNerindocianine
Drug Alias NameIRDye 800BK
ClassificationDiagnostic agent (In vivo) > Contrast agent
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsWounds and Injuries
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesLi-Cor Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLi-Cor Inc
Active IndicationsN/A
Inactive IndicationsWounds and Injuries

Other Information

ATC CodeN/A
Related LinksN/A